Ultrasmall Nanoparticles Regulate Immune Microenvironment by Activating IL‐33/ST2 to Alleviate Renal Ischemia‐Reperfusion Injury
Renal ischemia‐reperfusion injury (IRI) is a common disease with high morbidity and mortality. Renal IRI can cause the disorder of immune microenvironment and reprograming the immune microenvironment to alleviate excessive inflammatory response is crucial for its treatment. Cytokine IL‐33 can improv...
Gespeichert in:
| Veröffentlicht in: | Advanced healthcare materials 2024-05, Vol.13 (13), p.e2303276-n/a |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | n/a |
|---|---|
| container_issue | 13 |
| container_start_page | e2303276 |
| container_title | Advanced healthcare materials |
| container_volume | 13 |
| creator | Xu, Liyao Xing, Zhaoyu Yuan, Jiaxin Han, Yaobao Jiang, Zhilin Han, Mengxiao Hou, Xianao Xing, Wei Li, Zhen |
| description | Renal ischemia‐reperfusion injury (IRI) is a common disease with high morbidity and mortality. Renal IRI can cause the disorder of immune microenvironment and reprograming the immune microenvironment to alleviate excessive inflammatory response is crucial for its treatment. Cytokine IL‐33 can improve the immune inflammatory microenvironment by modulating both innate and adaptive immune cells, and serve as an important target for modulating immune microenvironment of renal IRI. Herein, we report that bilobetin‐functionalized ultrasmall Cu2−xSe nanoparticles (i.e., CSPB NPs) can activate the PKA/p‐CREB/IL‐33/ST2 signaling pathway to regulate innate and adaptive immune cells for reprograming the immune microenvironment of IRI‐induced acute kidney injury. The biocompatible CSPB NPs can promote the polarization of M1‐like macrophages into M2‐like macrophages, and the expansion of ILC2 and Treg cells by activating IL‐33/ST2 to modulate the excessive immune inflammatory response of renal IRI. More importantly, they can rapidly accumulate at the injured kidney to significantly alleviate IRI. This work demonstrates that modulating the expression of cytokines to reprogram immune microenvironment has great potential in the treatment of renal IRI and other ischemic diseases.
Bilobetin‐functionalized ultrasmall Cu2−xSe nanoparticles (i.e., CSPB NPs) can activate the PKA/p‐CREB/IL‐33/ST2 signaling pathway to regulate innate and adaptive immune cells for reprograming the immune microenvironment of ischemia‐reperfusion injury‐induced acute kidney injury (AKI) and alleviating AKI damage. |
| doi_str_mv | 10.1002/adhm.202303276 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2924999332</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2924999332</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3736-522ce3582a4b0de50e42ffd3ffd253fd484dcf030888bb70d3b4efe95865c7b13</originalsourceid><addsrcrecordid>eNqFkc9uEzEQxi0EolXplSOyxIVLUq9nvX-OUSl0pRSk0J4tr3e2dWR7g70blBuHPkCfkSfBUUqQuDDSaObw-z5p5iPkbcbmGWP8QnUPbs4ZBwa8LF6QU57VfMYLUb887jk7IecxrlmqQmRFlb0mJ1ABiCyHU_J4Z8egolPW0i_KDxsVRqMtRrrC-8mqEWnj3OSR3hgdBvRbEwbv0I-03dGFHs1Wjcbf02b56-cTwMW3W07HgS6sxa3Zy1folaVN1A_ojErQCjcY-imawdPGr6ewe0Ne9cpGPH-eZ-Tu09Xt5fVs-fVzc7lYzjSUUMwE5xpBVFzlLetQMMx533eQmgvou7zKO90zYFVVtW3JOmhz7LEWVSF02WZwRj4cfDdh-D5hHKUzUaO1yuMwRclrntd1DcAT-v4fdD1MIV0SJTAhKshYXSZqfqDSa2IM2MtNME6FncyY3Eck9xHJY0RJ8O7Zdmoddkf8TyAJqA_AD2Nx9x87ufh4ffPX_DdE9KAk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3055831097</pqid></control><display><type>article</type><title>Ultrasmall Nanoparticles Regulate Immune Microenvironment by Activating IL‐33/ST2 to Alleviate Renal Ischemia‐Reperfusion Injury</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Xu, Liyao ; Xing, Zhaoyu ; Yuan, Jiaxin ; Han, Yaobao ; Jiang, Zhilin ; Han, Mengxiao ; Hou, Xianao ; Xing, Wei ; Li, Zhen</creator><creatorcontrib>Xu, Liyao ; Xing, Zhaoyu ; Yuan, Jiaxin ; Han, Yaobao ; Jiang, Zhilin ; Han, Mengxiao ; Hou, Xianao ; Xing, Wei ; Li, Zhen</creatorcontrib><description>Renal ischemia‐reperfusion injury (IRI) is a common disease with high morbidity and mortality. Renal IRI can cause the disorder of immune microenvironment and reprograming the immune microenvironment to alleviate excessive inflammatory response is crucial for its treatment. Cytokine IL‐33 can improve the immune inflammatory microenvironment by modulating both innate and adaptive immune cells, and serve as an important target for modulating immune microenvironment of renal IRI. Herein, we report that bilobetin‐functionalized ultrasmall Cu2−xSe nanoparticles (i.e., CSPB NPs) can activate the PKA/p‐CREB/IL‐33/ST2 signaling pathway to regulate innate and adaptive immune cells for reprograming the immune microenvironment of IRI‐induced acute kidney injury. The biocompatible CSPB NPs can promote the polarization of M1‐like macrophages into M2‐like macrophages, and the expansion of ILC2 and Treg cells by activating IL‐33/ST2 to modulate the excessive immune inflammatory response of renal IRI. More importantly, they can rapidly accumulate at the injured kidney to significantly alleviate IRI. This work demonstrates that modulating the expression of cytokines to reprogram immune microenvironment has great potential in the treatment of renal IRI and other ischemic diseases.
Bilobetin‐functionalized ultrasmall Cu2−xSe nanoparticles (i.e., CSPB NPs) can activate the PKA/p‐CREB/IL‐33/ST2 signaling pathway to regulate innate and adaptive immune cells for reprograming the immune microenvironment of ischemia‐reperfusion injury‐induced acute kidney injury (AKI) and alleviating AKI damage.</description><identifier>ISSN: 2192-2640</identifier><identifier>ISSN: 2192-2659</identifier><identifier>EISSN: 2192-2659</identifier><identifier>DOI: 10.1002/adhm.202303276</identifier><identifier>PMID: 38335143</identifier><language>eng</language><publisher>Germany: Wiley Subscription Services, Inc</publisher><subject>Acute Kidney Injury - drug therapy ; Acute Kidney Injury - metabolism ; Acute Kidney Injury - pathology ; Animals ; Biocompatibility ; Cu2−xSe nanoparticles ; Cyclic AMP response element-binding protein ; Cytokines ; Health services ; IL‐33/ST2 ; immune microenvironment ; Immune system ; Inflammation ; Inflammatory response ; Injuries ; Interleukin-1 Receptor-Like 1 Protein - metabolism ; Interleukin-33 - metabolism ; Ischemia ; ischemia‐reperfusion injury ; Kidney - drug effects ; Kidney - metabolism ; Kidney - pathology ; Kidneys ; Lymphocytes T ; M2 macrophage polarization ; Macrophages ; Macrophages - drug effects ; Macrophages - immunology ; Macrophages - metabolism ; Male ; Mice ; Mice, Inbred C57BL ; Morbidity ; Nanoparticles ; Nanoparticles - chemistry ; Protein kinase A ; RAW 264.7 Cells ; Reperfusion ; Reperfusion Injury - drug therapy ; Reperfusion Injury - immunology ; Reperfusion Injury - metabolism ; Signal transduction ; Signal Transduction - drug effects</subject><ispartof>Advanced healthcare materials, 2024-05, Vol.13 (13), p.e2303276-n/a</ispartof><rights>2024 Wiley‐VCH GmbH</rights><rights>2024 Wiley‐VCH GmbH.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3736-522ce3582a4b0de50e42ffd3ffd253fd484dcf030888bb70d3b4efe95865c7b13</citedby><cites>FETCH-LOGICAL-c3736-522ce3582a4b0de50e42ffd3ffd253fd484dcf030888bb70d3b4efe95865c7b13</cites><orcidid>0000-0003-0333-7699</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fadhm.202303276$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fadhm.202303276$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38335143$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xu, Liyao</creatorcontrib><creatorcontrib>Xing, Zhaoyu</creatorcontrib><creatorcontrib>Yuan, Jiaxin</creatorcontrib><creatorcontrib>Han, Yaobao</creatorcontrib><creatorcontrib>Jiang, Zhilin</creatorcontrib><creatorcontrib>Han, Mengxiao</creatorcontrib><creatorcontrib>Hou, Xianao</creatorcontrib><creatorcontrib>Xing, Wei</creatorcontrib><creatorcontrib>Li, Zhen</creatorcontrib><title>Ultrasmall Nanoparticles Regulate Immune Microenvironment by Activating IL‐33/ST2 to Alleviate Renal Ischemia‐Reperfusion Injury</title><title>Advanced healthcare materials</title><addtitle>Adv Healthc Mater</addtitle><description>Renal ischemia‐reperfusion injury (IRI) is a common disease with high morbidity and mortality. Renal IRI can cause the disorder of immune microenvironment and reprograming the immune microenvironment to alleviate excessive inflammatory response is crucial for its treatment. Cytokine IL‐33 can improve the immune inflammatory microenvironment by modulating both innate and adaptive immune cells, and serve as an important target for modulating immune microenvironment of renal IRI. Herein, we report that bilobetin‐functionalized ultrasmall Cu2−xSe nanoparticles (i.e., CSPB NPs) can activate the PKA/p‐CREB/IL‐33/ST2 signaling pathway to regulate innate and adaptive immune cells for reprograming the immune microenvironment of IRI‐induced acute kidney injury. The biocompatible CSPB NPs can promote the polarization of M1‐like macrophages into M2‐like macrophages, and the expansion of ILC2 and Treg cells by activating IL‐33/ST2 to modulate the excessive immune inflammatory response of renal IRI. More importantly, they can rapidly accumulate at the injured kidney to significantly alleviate IRI. This work demonstrates that modulating the expression of cytokines to reprogram immune microenvironment has great potential in the treatment of renal IRI and other ischemic diseases.
Bilobetin‐functionalized ultrasmall Cu2−xSe nanoparticles (i.e., CSPB NPs) can activate the PKA/p‐CREB/IL‐33/ST2 signaling pathway to regulate innate and adaptive immune cells for reprograming the immune microenvironment of ischemia‐reperfusion injury‐induced acute kidney injury (AKI) and alleviating AKI damage.</description><subject>Acute Kidney Injury - drug therapy</subject><subject>Acute Kidney Injury - metabolism</subject><subject>Acute Kidney Injury - pathology</subject><subject>Animals</subject><subject>Biocompatibility</subject><subject>Cu2−xSe nanoparticles</subject><subject>Cyclic AMP response element-binding protein</subject><subject>Cytokines</subject><subject>Health services</subject><subject>IL‐33/ST2</subject><subject>immune microenvironment</subject><subject>Immune system</subject><subject>Inflammation</subject><subject>Inflammatory response</subject><subject>Injuries</subject><subject>Interleukin-1 Receptor-Like 1 Protein - metabolism</subject><subject>Interleukin-33 - metabolism</subject><subject>Ischemia</subject><subject>ischemia‐reperfusion injury</subject><subject>Kidney - drug effects</subject><subject>Kidney - metabolism</subject><subject>Kidney - pathology</subject><subject>Kidneys</subject><subject>Lymphocytes T</subject><subject>M2 macrophage polarization</subject><subject>Macrophages</subject><subject>Macrophages - drug effects</subject><subject>Macrophages - immunology</subject><subject>Macrophages - metabolism</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Morbidity</subject><subject>Nanoparticles</subject><subject>Nanoparticles - chemistry</subject><subject>Protein kinase A</subject><subject>RAW 264.7 Cells</subject><subject>Reperfusion</subject><subject>Reperfusion Injury - drug therapy</subject><subject>Reperfusion Injury - immunology</subject><subject>Reperfusion Injury - metabolism</subject><subject>Signal transduction</subject><subject>Signal Transduction - drug effects</subject><issn>2192-2640</issn><issn>2192-2659</issn><issn>2192-2659</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc9uEzEQxi0EolXplSOyxIVLUq9nvX-OUSl0pRSk0J4tr3e2dWR7g70blBuHPkCfkSfBUUqQuDDSaObw-z5p5iPkbcbmGWP8QnUPbs4ZBwa8LF6QU57VfMYLUb887jk7IecxrlmqQmRFlb0mJ1ABiCyHU_J4Z8egolPW0i_KDxsVRqMtRrrC-8mqEWnj3OSR3hgdBvRbEwbv0I-03dGFHs1Wjcbf02b56-cTwMW3W07HgS6sxa3Zy1folaVN1A_ojErQCjcY-imawdPGr6ewe0Ne9cpGPH-eZ-Tu09Xt5fVs-fVzc7lYzjSUUMwE5xpBVFzlLetQMMx533eQmgvou7zKO90zYFVVtW3JOmhz7LEWVSF02WZwRj4cfDdh-D5hHKUzUaO1yuMwRclrntd1DcAT-v4fdD1MIV0SJTAhKshYXSZqfqDSa2IM2MtNME6FncyY3Eck9xHJY0RJ8O7Zdmoddkf8TyAJqA_AD2Nx9x87ufh4ffPX_DdE9KAk</recordid><startdate>20240501</startdate><enddate>20240501</enddate><creator>Xu, Liyao</creator><creator>Xing, Zhaoyu</creator><creator>Yuan, Jiaxin</creator><creator>Han, Yaobao</creator><creator>Jiang, Zhilin</creator><creator>Han, Mengxiao</creator><creator>Hou, Xianao</creator><creator>Xing, Wei</creator><creator>Li, Zhen</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QF</scope><scope>7QP</scope><scope>7QQ</scope><scope>7SC</scope><scope>7SE</scope><scope>7SP</scope><scope>7SR</scope><scope>7T5</scope><scope>7TA</scope><scope>7TB</scope><scope>7TM</scope><scope>7TO</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>F28</scope><scope>FR3</scope><scope>H8D</scope><scope>H8G</scope><scope>H94</scope><scope>JG9</scope><scope>JQ2</scope><scope>K9.</scope><scope>KR7</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0333-7699</orcidid></search><sort><creationdate>20240501</creationdate><title>Ultrasmall Nanoparticles Regulate Immune Microenvironment by Activating IL‐33/ST2 to Alleviate Renal Ischemia‐Reperfusion Injury</title><author>Xu, Liyao ; Xing, Zhaoyu ; Yuan, Jiaxin ; Han, Yaobao ; Jiang, Zhilin ; Han, Mengxiao ; Hou, Xianao ; Xing, Wei ; Li, Zhen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3736-522ce3582a4b0de50e42ffd3ffd253fd484dcf030888bb70d3b4efe95865c7b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Acute Kidney Injury - drug therapy</topic><topic>Acute Kidney Injury - metabolism</topic><topic>Acute Kidney Injury - pathology</topic><topic>Animals</topic><topic>Biocompatibility</topic><topic>Cu2−xSe nanoparticles</topic><topic>Cyclic AMP response element-binding protein</topic><topic>Cytokines</topic><topic>Health services</topic><topic>IL‐33/ST2</topic><topic>immune microenvironment</topic><topic>Immune system</topic><topic>Inflammation</topic><topic>Inflammatory response</topic><topic>Injuries</topic><topic>Interleukin-1 Receptor-Like 1 Protein - metabolism</topic><topic>Interleukin-33 - metabolism</topic><topic>Ischemia</topic><topic>ischemia‐reperfusion injury</topic><topic>Kidney - drug effects</topic><topic>Kidney - metabolism</topic><topic>Kidney - pathology</topic><topic>Kidneys</topic><topic>Lymphocytes T</topic><topic>M2 macrophage polarization</topic><topic>Macrophages</topic><topic>Macrophages - drug effects</topic><topic>Macrophages - immunology</topic><topic>Macrophages - metabolism</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Morbidity</topic><topic>Nanoparticles</topic><topic>Nanoparticles - chemistry</topic><topic>Protein kinase A</topic><topic>RAW 264.7 Cells</topic><topic>Reperfusion</topic><topic>Reperfusion Injury - drug therapy</topic><topic>Reperfusion Injury - immunology</topic><topic>Reperfusion Injury - metabolism</topic><topic>Signal transduction</topic><topic>Signal Transduction - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xu, Liyao</creatorcontrib><creatorcontrib>Xing, Zhaoyu</creatorcontrib><creatorcontrib>Yuan, Jiaxin</creatorcontrib><creatorcontrib>Han, Yaobao</creatorcontrib><creatorcontrib>Jiang, Zhilin</creatorcontrib><creatorcontrib>Han, Mengxiao</creatorcontrib><creatorcontrib>Hou, Xianao</creatorcontrib><creatorcontrib>Xing, Wei</creatorcontrib><creatorcontrib>Li, Zhen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Aluminium Industry Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Ceramic Abstracts</collection><collection>Computer and Information Systems Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Electronics & Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Immunology Abstracts</collection><collection>Materials Business File</collection><collection>Mechanical & Transportation Engineering Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>ANTE: Abstracts in New Technology & Engineering</collection><collection>Engineering Research Database</collection><collection>Aerospace Database</collection><collection>Copper Technical Reference Library</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>MEDLINE - Academic</collection><jtitle>Advanced healthcare materials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xu, Liyao</au><au>Xing, Zhaoyu</au><au>Yuan, Jiaxin</au><au>Han, Yaobao</au><au>Jiang, Zhilin</au><au>Han, Mengxiao</au><au>Hou, Xianao</au><au>Xing, Wei</au><au>Li, Zhen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ultrasmall Nanoparticles Regulate Immune Microenvironment by Activating IL‐33/ST2 to Alleviate Renal Ischemia‐Reperfusion Injury</atitle><jtitle>Advanced healthcare materials</jtitle><addtitle>Adv Healthc Mater</addtitle><date>2024-05-01</date><risdate>2024</risdate><volume>13</volume><issue>13</issue><spage>e2303276</spage><epage>n/a</epage><pages>e2303276-n/a</pages><issn>2192-2640</issn><issn>2192-2659</issn><eissn>2192-2659</eissn><abstract>Renal ischemia‐reperfusion injury (IRI) is a common disease with high morbidity and mortality. Renal IRI can cause the disorder of immune microenvironment and reprograming the immune microenvironment to alleviate excessive inflammatory response is crucial for its treatment. Cytokine IL‐33 can improve the immune inflammatory microenvironment by modulating both innate and adaptive immune cells, and serve as an important target for modulating immune microenvironment of renal IRI. Herein, we report that bilobetin‐functionalized ultrasmall Cu2−xSe nanoparticles (i.e., CSPB NPs) can activate the PKA/p‐CREB/IL‐33/ST2 signaling pathway to regulate innate and adaptive immune cells for reprograming the immune microenvironment of IRI‐induced acute kidney injury. The biocompatible CSPB NPs can promote the polarization of M1‐like macrophages into M2‐like macrophages, and the expansion of ILC2 and Treg cells by activating IL‐33/ST2 to modulate the excessive immune inflammatory response of renal IRI. More importantly, they can rapidly accumulate at the injured kidney to significantly alleviate IRI. This work demonstrates that modulating the expression of cytokines to reprogram immune microenvironment has great potential in the treatment of renal IRI and other ischemic diseases.
Bilobetin‐functionalized ultrasmall Cu2−xSe nanoparticles (i.e., CSPB NPs) can activate the PKA/p‐CREB/IL‐33/ST2 signaling pathway to regulate innate and adaptive immune cells for reprograming the immune microenvironment of ischemia‐reperfusion injury‐induced acute kidney injury (AKI) and alleviating AKI damage.</abstract><cop>Germany</cop><pub>Wiley Subscription Services, Inc</pub><pmid>38335143</pmid><doi>10.1002/adhm.202303276</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0003-0333-7699</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2192-2640 |
| ispartof | Advanced healthcare materials, 2024-05, Vol.13 (13), p.e2303276-n/a |
| issn | 2192-2640 2192-2659 2192-2659 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2924999332 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Acute Kidney Injury - drug therapy Acute Kidney Injury - metabolism Acute Kidney Injury - pathology Animals Biocompatibility Cu2−xSe nanoparticles Cyclic AMP response element-binding protein Cytokines Health services IL‐33/ST2 immune microenvironment Immune system Inflammation Inflammatory response Injuries Interleukin-1 Receptor-Like 1 Protein - metabolism Interleukin-33 - metabolism Ischemia ischemia‐reperfusion injury Kidney - drug effects Kidney - metabolism Kidney - pathology Kidneys Lymphocytes T M2 macrophage polarization Macrophages Macrophages - drug effects Macrophages - immunology Macrophages - metabolism Male Mice Mice, Inbred C57BL Morbidity Nanoparticles Nanoparticles - chemistry Protein kinase A RAW 264.7 Cells Reperfusion Reperfusion Injury - drug therapy Reperfusion Injury - immunology Reperfusion Injury - metabolism Signal transduction Signal Transduction - drug effects |
| title | Ultrasmall Nanoparticles Regulate Immune Microenvironment by Activating IL‐33/ST2 to Alleviate Renal Ischemia‐Reperfusion Injury |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T06%3A19%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ultrasmall%20Nanoparticles%20Regulate%20Immune%20Microenvironment%20by%20Activating%20IL%E2%80%9033/ST2%20to%20Alleviate%20Renal%20Ischemia%E2%80%90Reperfusion%20Injury&rft.jtitle=Advanced%20healthcare%20materials&rft.au=Xu,%20Liyao&rft.date=2024-05-01&rft.volume=13&rft.issue=13&rft.spage=e2303276&rft.epage=n/a&rft.pages=e2303276-n/a&rft.issn=2192-2640&rft.eissn=2192-2659&rft_id=info:doi/10.1002/adhm.202303276&rft_dat=%3Cproquest_cross%3E2924999332%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3055831097&rft_id=info:pmid/38335143&rfr_iscdi=true |